$EBYH NEWS! New York, N.Y., December 10, 2019 -- Strainsforpains, Inc. (OTC Pink:EBYH) is pleased to announce the following shareholder update. Regarding recent material events. We have developed and launched our medical cannabis search engine APP that will revolutionize the medical cannabis technology industry. With 33 states approving medical cannabis, we see substantial revenue growth for the industry from 7 billion to over 20 billion from 2018 to 2021. We believe that our APP is essential in offering valuable, reliable and responsible information to patients, doctors and dispensaries.
We are currently attending the MJ Biz Conference in Las Vegas from December 11-13, 2019 at booth C8911. We intend to close on joint ventures and sign letters of intent with a variety of companies at this show and others we will be attending and speaking at in 2020. We will update the public through social media and press release as they become active.
We also have updated our website and will soon have products for sale there too. As our APP becomes more known we will venture into product sale in 2020. We will subsequently start our advertising campaign in the first quarter of 2020, and we are in the process of selecting an advertising partner. Our APP is far advanced in anything out there today with a variety features, and easy end user accessibility. Management believes that 2020 will show strong revenue growth, and will continue to utilize this momentum in our acquisition strategies.
With skyrocketing health care costs, most people are finally awakening to the values of CBD as a natural and safe alternative therapy, as well as cannabis for medical relief of pain. We will release announcements in the near future about our own CBD brand and consumer line of products.
To learn more about the company and our APP please visit our website
at strainsforpains.com/
About Strainsforpains, Inc.
Strainsforpains, Inc. is an innovative healthcare technology company located in New York, N.Y. The Company's objectives are threefold: (1) To provide doctors, dispensaries and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of Cannabis combinations with major illnesses in a user friendly manner;
and (2) acquisitions within the cannabis and CBD industry; and (3) providing a line of CBD products in the marketplace.
